Real-time insights. Smarter decisions. Better trades.
🔍 Search StocksConfidence: 35%
Date: 21-04-2026
Price: $0.002
Last Price: $0.130
Post-Signal Peak Price: $0.210
Presenting Companies to Host 25 Minute Presentations Followed by Question-and-Answer Session; Conference Open to all Retail and Institutional Investors NEW YORK, June 21, 2022 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading small-capitalization equity research and conference provider, will h
30 Minute presenting time slots from 9am to 1pm EST November 16, 2021 Presentation times and links distributed for all presenting companies Investors will be provided time after presentation to ask questions Welcome all institutional and retail investors NEW YORK, Nov. 15, 2021 (GLOBE NEWSWIRE) --
AI Confidence - 35 % model confidence
Chimeric Therapeutics Limited is an Australian biotechnology company focused on developing innovative CAR T-cell therapies targeting solid tumors. Positioned in the emerging immuno-oncology sector, the company aims to address significant unmet medical needs with its proprietary chimeric antigen receptor technology, targeting cancers with high mortality rates and limited treatment options.
| Cash Flow | Weak |
| Debt | Low |
| Profitability | Weak |
| Revenue Trend | Unknown |
| Trend | Bullish |
| Momentum | Moderate |
| RSI Signal | Neutral |
| Support Level | $ 0.0018 |
| Resistance Level | $ 0.0025 |